OptiCept Technologies
Correction: OptiCept Technologies Interim Report Q2 2025
The correction refers to an adjustment of the heading, where it previously stated 'Q1'.
OptiCept Technologies AB (publ), today published its Interim Report for Q2 2025 (April – June 2025).
SIGNIFICANT EVENTS Q2 2025
• OptiCept receives key order from existing customer in Spain
• OptiCept Technologies AB publishes annual report for 2024
• OptiCept granted a new patent for the treatment of liquid food products
• OptiCept secures 37 MSEK in financing (SEK 29 million settled in Q2 and SEK 8 million in Q3) – aiming for positive cash flow and broad commercial expansion
• OptiCept Initiates Collaboration with Tropical Food Machinery
• OptiCept Receives Order for CEPT® System for Olive Oil Extraction from Spanish Producer
• OptiCept Launches Validation Project with Leading Juice Producer in Vietnam
• OptiCept Receives Order from Dole Worth 4 MSEK
• New order from Spain: OptiCept’s CEPT® technology chosen for olive oil extra
SIGNIFICANT EVENTS AFTER PERIOD END
• OptiCept signs agreement with world-leading producer of alcoholic beverages
• New Order from Spain – OptiCept Continues to Gain Ground in the Olive Oil Industry
• OptiCept receives third order from Spanish customer – continues expansion in the olive oil industry
• OptiCept receives order worth approximately SEK 3.6 million from leading olive oil producer in Spain
• Breakthrough in a fast-growing market: OptiCept secures SEK 2 million order in avocado oil extraction
• New Patent Strengthens OptiCept Technologies’ Market Position
• OptiCept Technologies AB changes Certified Adviser to Tapper Partners AB
FINANCIAL OVERVIEW | ||||
KSEK (unless otherwise stated)* | Q2 (apr-jun) | Q1-Q2 (jan-juni) | ||
2025 | 2024 | 2025 | 2024 | |
Net Sales** | 1 192 | 4 808 | 6 470 | 8 406 |
Total revenue** | 3 245 | 12 577 | 11 444 | 18 486 |
Operating Income | -18 612 | -9 663 | -33 621 | -26 120 |
Result for the period | -19 097 | -10 213 | -35 060 | -25 018 |
Inbound Orders*** | 15 801 | 6 836 | 17 933 | 9 196 |
Open orders*** | 19 457 | 10 222 | 19 457 | 10 222 |
Reported EBITDA | -16 025 | -6 252 | -28 441 | -17 746 |
Net result for the period | 382 572 | 376 425 | 382 572 | 376 425 |
Cash & cash equivalents | 12 043 | 4 022 | 12 043 | 4 022 |
Equity | 331 995 | 340 494 | 331 995 | 340 494 |
Equity ratio (%) | 87% | 90% | 87% | 90% |
Average number of shares in the period | 62 823 850 | 44 181 669 | 62 823 850 | 44 181 669 |
Number of shares at the end of the period | 64 394 683 | 47 146 408 | 64 394 683 | 47 146 408 |
Earnings per share before and after dilution (SEK) | -0,30 | -0,23 | -0,56 | -0,57 |
Cash flow from operating activities | -9 743 | -12 108 | -19 972 | -21 762 |
Total Cash flow | 5 161 | -7 845 | -9 633 | -10 093 |
For information regarding alternative performance measures, please refer to Note 5. | ||||
* Rounding may occur so that, in some cases, the amounts do not add up | ||||
** For information regarding net revenue, please refer to Note 2. | ||||
***Open orders excluding FPS, please refer to Note 1 |
”Step by step, we are moving towards the position of becoming the leading supplier of PEF in every segment of the food industry where we establish ourselves,” comments Thomas Lundqvist, CEO, OptiCept Technologies.
The report is available on the company's website: https://investor.opticept.se/finansiell-information/finansiella-rapporter/
Datum | 2025-08-28, kl 08:55 |
Källa | MFN |